COST-EFFECTIVENESS OF TREATING METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS WHOSE DISEASE FAILED ON VEGF-TKI THERAPIES WITH EVEROLIMUS COMPARED TO TREATING WITH BEST SUPPORTIVE CARE (BSC) ALONE: A CANADIAN SOCIETAL PERSPECTIVE

被引：0
|
作者：
El Ouagari, K. [1 ]
Chulikavit, M. [2 ]
机构：
[1] Novartis Pharmaceut, Hlth Econ & Pricing, Dorval, PQ, Canada
[2] Analyt Int, New York, NY USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：291 / 291
页数：1
相关论文
共 4 条
  • [1] COST-EFFECTIVENESS OF TREATING METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS WHOSE DISEASE FAILED ON ONE PRIOR VEGF-TKI THERAPY WITH EVEROLIMUS COMPARED TO TREATING WITH BEST SUPPORTIVE CARE (BSC) ALONE IN CANADA
    Casciano, R.
    Chulikavit, M.
    El Ouagari, K.
    Wang, X.
    VALUE IN HEALTH, 2011, 14 (07) : A445 - A446
  • [2] COST-EFFECTIVENESS ANALYSIS OF SORAFENIB ASSOCIATED TO BEST SUPPORTIVE CARE (BSC) VERSUS BEST SUPPORTIVE CARE ALONE IN THE SECOND LINE TREATMENT OF ADVANCED RENAL CELL CARCINOMA UNDER THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM PERSPECTIVE
    Teich, V
    Fernandes, R. A.
    Schiola, A.
    VALUE IN HEALTH, 2009, 12 (03) : A42 - A42
  • [3] COST-EFFECTIVENESS OF PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) COMPARED WITH BSC ALONE IN CHEMOREFRACTORY METASTATIC COLORECTAL CANCER (MCRC) PATIENTS (PTS) WITH WILD-TYPE (WT) KRAS TUMOR STATUS IN THE NETHERLANDS
    Graham, C. N.
    Borker, R.
    Oppe, M.
    Groot, C. A. Uyl-de
    Barber, B.
    Brogan, A. J.
    Amado, R. G.
    Peeters, M.
    Devercelli, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 134 - 134
  • [4] COST-EFFECTIVENESS ANALYSIS OF AVELUMAB PLUS BEST SUPPORTIVE CARE (BSC) VS BSC ALONE AS A FIRST-LINE (1L) MAINTENANCE TREATMENT FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN TAIWAN
    Chang, Wc
    Xiao, Y.
    Lin, Ay
    Pj, Su
    Goh, C.
    Wu, E.
    Liu, K.
    Chou, P.
    Kuo, K.
    Palencia, R.
    Chang, J.
    Kearney, M.
    Kapetanakis, V
    Benedict, A.
    VALUE IN HEALTH, 2022, 25 (01) : S58 - S59
1